Clinical research - Press Releases

Date	Title	Company
20-Jul-2022	Almirall launches new call to find innovative therapies for skin diseases	Almirall
20-Jul-2022	Resolution Therapeutics Appoints Dr. Bill Symonds to its Board of Directors	Resolution Therapeutics
19-Jul-2022	AARDEX® Group and BIOCORP Recruited by Trials@Home - Decentralized Clinical Trial Centre of Excellence	AARDEX® Group
18-Jul-2022	Oxford Science Enterprises Raises £250 Million	Oxford Science
18-Jul-2022	Enterome signs major strategic R&D collaboration with Nestlé Health Science to develop and commercialize new AllerMimics™ and EndoMimics™ immunotherapies for food allergies and inflammatory bowel disease	Enterome
18-Jul-2022	Bone Therapeutics optimizes statistical analysis and introduces interim analysis in the ongoing ALLOB Phase IIb study for high-risk tibial fractures	Bone Therapeutics
14-Jul-2022	Brits have worst mental health in Europe, STADA Health Report 2022 reveals	The STADA Group
14-Jul-2022	PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate	PureTech Health plc
14-Jul-2022	TANIOBIS invests in new test and production plant for chlorides	TANIOBIS
14-Jul-2022	83% fewer vaccinated women hospitalised during pregnancy – but only Omicron jab can maintain success	New Office for National Statistics
14-Jul-2022	Nanoform and Pharmanovia to breathe new life into iconic medicines	Nanoform Finland Plc
14-Jul-2022	Grünenthal acquires testosterone treatment Nebido™ from Bayer	Bayer
14-Jul-2022	Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis	Sanofi
13-Jul-2022	Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea	Novotech Health Holdings Pte Ltd
13-Jul-2022	PharmiWeb.Jobs Welcomes Excelya	PharmiWeb.Jobs
12-Jul-2022	Scottish Medicines Consortium issues interim acceptance to Novartis’ Adakveo®▼ (crizanlizumab) for preventing recurrent vaso-occlusive crises, the first treatment for sickle cell disorder in over 20 years	Novartis
12-Jul-2022	Research shows investigational drug fosters nerve repair after injury	University of Brimingham
12-Jul-2022	ABB and Red Hat partner to deliver further scalable digital solutions across industrial edge and hybrid cloud	ABB
08-Jul-2022	Healthcare Patent Filing Outsourcing Market Size is Projected to Reach USD 2,434.2 Million by 2027 At 6% CAGR Fueled by Rising Patent Registrations in Healthcare Sector	Acumen Research And Consulting
04-Jul-2022	Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years	Takeda